Investigation Report on China's Paclitaxel Market 2021-2025

SKU ID :CRI-18360561 | Published Date: 28-May-2021 | No. of pages: 50
Table of Contents 1 Relevant Concepts of Paclitaxel        1.1 Indications for Paclitaxel        1.2 Development of Paclitaxel in China 1.3 Governmental Approval of Paclitaxel in China 1.4 The Impact of COVID-19 on Paclitaxel sales in China 2 Sales of Paclitaxel in China, 2016-2020    2.1 Sales Value of Paclitaxel 2.1.1 Overall Sales Value 2.1.2 Sales Value by Regions 2.2 Sales Volume of Paclitaxel      2.2.1 Overall Sales Volume   2.2.2 Sales Volume by Regions     2.3 Sales of Paclitaxel by Dosage Form in China, 2016-2020     2.3.1 Liposome injection 2.3.2 Injection (nanoparticle albumin-bound) 2.3.3 Injection 2.3.4 Analysis of Other Dosage Forms        3 Analysis of Major Paclitaxel Manufacturers in China, 2016-2020    3.1 Analysis of Market Share of Major Paclitaxel Manufacturers 3.1.1 Investigation on Market Share by Sales Value     3.1.2 Investigation on Market Share by Sales volume  3.2 Nanjing Luye Pharmaceutical Co., Ltd.  3.2.1 Enterprise Profile  3.2.2 Sales of LIPOSOME (Nanjing Luye Pharmaceutical Co., Ltd.’s Paclitaxel) in China 3.3  CSPC Ouyi Pharmaceutical Group Co., Ltd. 3.3.1 Enterprise Profile  3.3.2 Sales of Keaili (CSPC Ouyi Pharmaceutical Group Co., Ltd.’s Paclitaxel) in China 3.4 Jiangsu Hengrui Pharmaceutical Co., Ltd. 3.4.1 Enterprise Profile  3.4.2 Sales of Aiyue (Jiangsu Hengrui Pharmaceutical Co., Ltd.’s Paclitaxel) in China 3.5 Hospira Australia Pty Ltd 3.5.1 Enterprise Profile  3.5.2 Sales of Paclitaxel (Hospira Australia Pty Ltd’s Paclitaxel) in China 3.6 Beistol-Myers Squibb S.r.l. 3.6.1 Enterprise Profile  3.6.2 Sales of TAXOL (Beistol-Myers Squibb S.r.l.’s Paclitaxel) in China 4 Prices of Paclitaxel for Different Manufacturers in China, 2020-2021 4.1 Nanjing Luye Pharmaceutical Co., Ltd. (LIPOSOME)  4.2 CSPC Ouyi Pharmaceutical Group Co., Ltd. (Keaili) 4.3 Jiangsu Hengrui Pharmaceutical Co., Ltd. (Aiyue) 4.4 Hospira Australia Pty Ltd (ANZATAX) 4.5 Beistol-Myers Squibb S.r.l.(TAXOL) 5 Prospect of Chinese Paclitaxel Market, 2021-2025 5.1 Influential Factors of Chinese Paclitaxel Market Development 5.1.1 The Impact of COVID-19 on Chinese Paclitaxel Market 5.1.2 Market Drivers and Opportunities 5.1.3 Market Threats and Challenges 5.2 Forecast on Market Size  5.3 Forecast on Market Trend List of Charts Chart Patent Information About Paclitaxel Liposome Injection Registration in China Chart Patent Information About Paclitaxel (Nanoparticle Albumin-bound) Injection Registration in China Chart Patent Information About Paclitaxel Injection Registration in China Chart Sales Value of Paclitaxel Liposome Injection over the World    Chart Sales Value of Paclitaxel Injection (Nanoparticle Albumin-bound) over the World Chart Sales Value of Paclitaxel Injection over the World Chart Sales Value of Paclitaxel Liposome Injection in China, 2016-2020   Chart Sales Value of Paclitaxel Injection (Nanoparticle Albumin-bound) in China, 2016-2020 Chart Sales Value of Paclitaxel Injection in China, 2016-2020 Chart Sales Value of Paclitaxel Liposome Injection in China by Regions, 2016-2020 Chart Sales Value of Paclitaxel Injection (Nanoparticle Albumin-bound) in China by Regions, 2016-2020 Chart Sales Value of Paclitaxel Injection in China by Regions, 2016-2020 Chart Sales Volume of Paclitaxel Liposome Injection in China, 2016-2020 Chart Sales Volume of Paclitaxel Injection (Nanoparticle Albumin-bound) in China, 2016-2020 Chart Sales Volume of Paclitaxel Injection in China, 2016-2020 Chart Sales Volume of Paclitaxel Liposome Injection in China by Regions, 2016-2020 Chart Sales Volume of Paclitaxel Injection (Nanoparticle Albumin-bound) in China by Regions, 2016-2020 Chart Sales Volume of Paclitaxel Injection in China by Regions, 2016-2020 Chart Market Share by Sales Value of Top Paclitaxel Manufacturers in China, 2016-2020 Chart Market Share by Sales Value of Top Paclitaxel Manufacturers in China, 2016-2020 Chart Market Share by Sales Value of Top Injection Manufacturers in China, 2016-2020 Chart Sales Value and Volume of LIPOSOME in China, 2016-2020 Chart Sales Value and Volume of Keaili in China, 2016-2020 Chart Sales Value and Volume of Aiyue in China, 2016-2020 Chart Sales Value and Volume of ANZATAX in China, 2016-2020 Chart Sales Value and Volume of TAXOL in China, 2016-2020         Chart Referential Prices of LIPOSOME in China by Regions, 2020-2021         Chart Referential Prices of Keaili in China by Regions, 2020-2021 Chart Referential Prices of Aiyue in China by Regions, 2020-2021      Chart Referential Prices of ANZATAX in China by Regions, 2020-2021           Chart Referential Prices of TAXOL in China by Regions, 2020-2021 Chart Forecast on Sales Value of Liposome Injection in China, 2021-2025 Chart Forecast on Sales Value of Injection (Nanoparticle Albumin-bound) in China, 2021-2025 Chart Forecast on Sales Value of Injection in China, 2021-2025 Chart Forecast on Sales Volume of Liposome Injection in China, 2021-2025 Chart Forecast on Sales Volume of Injection (Nanoparticle Albumin-bound) in China, 2021-2025 Chart Forecast on Sales Volume of Injection in China, 2021-2025
  • PRICE
  • $2600
    $3900

Our Clients